SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-010378
Filing Date
2022-03-15
Accepted
2022-03-15 16:05:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A evok-defa14a_20220427.htm DEFA14A 18203
2 GRAPHIC g2p3c5jkrpxk000001.jpg GRAPHIC 606157
3 GRAPHIC g2p3c5jkrpxk000002.jpg GRAPHIC 218754
  Complete submission text file 0001564590-22-010378.txt   1155419
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36075 | Film No.: 22741075
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences